Brief: Clinuvel Pharmaceuticals Enters Strategic Partnership With Valentech Pharma
23/05/2024 02:17
May 23 (Reuters) - Clinuvel Pharmaceuticals Ltd
CUV.AX :
* ENTERED A STRATEGIC PARTNERSHIP WITH VALENTECH PHARMA TO
INTRODUCE SCENESSE IN LATIN AMERICA
Source text for Eikon: ID:nASXqBqRC
Further company coverage: CUV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist